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Association of Skin Barrier Genes within the PSORS4
Locus Is Enriched in Singaporean Chinese with
Early-Onset Psoriasis
Huijia Chen1,2, Terry K. L. Toh3, Ildiko Szeverenyi2, Rick T. H. Ong3, Colin T. S. Theng4,
W. H. Irwin McLean2, Mark Seielstad3 and E. Birgitte Lane1
Psoriasis (OMIM#177900) is a common polygenic skin disorder affecting approximately 2% of the northern
European population and 0.1% of the Han Chinese. Psoriasis patients suffer from chronic skin inflammation,
manifested by erythematous scaly lesions. PSORS1–PSORS9 have been confirmed as psoriasis susceptibility loci
in independent genetic studies on predominantly Caucasian populations, with psoriasis susceptibility loci
(PSORS1, PSORS9) and additional loci at 9q33-34 and 2p22.3-11.2 reported in Han Chinese patients. In this study,
we show the association of PSORS4 with psoriasis in Singaporean Chinese. Dense genotyping of single-
nucleotide polymorphism-tagging candidate genes within the epidermal differentiation complex revealed
significant association in the proximity of the involucrin gene (IVL); the strongest association was seen in early-
onset psoriasis patients (P¼ 0.0014). A follow-up genome-wide association screen localized the psoriasis
susceptibility region toB360 kb along chromosome 1 in the vicinity of IVL, small proline-rich region (SPRR) and
proline-rich region 9 (PRR9) genes. The study of interactions between the causative variant(s) in this locus will
provide insights into a possible role for epidermal barrier formation in the pathogenesis of psoriasis.
Journal of Investigative Dermatology (2009) 129, 606–614; doi:10.1038/jid.2008.273; published online 11 September 2008
INTRODUCTION
Psoriasis (OMIM#177900) is a common skin disorder
affecting approximately 2% of the northern European
population (Nevitt and Hutchinson, 1996) and 0.1% of the
Han Chinese (Shao, 1996). Affected people suffer from
chronic skin inflammation, manifested by erythematous scaly
lesions that can be distributed over the scalp, palms, soles,
and extensor surfaces of the limbs (Schon and Boehncke,
2005). At the microscopic level, psoriatic skin demonstrates
features of abnormal differentiation (hyperkeratosis, paraker-
atosis) in the upper epidermal layers (Leigh et al., 1985) and
inflammation (neutrophil infiltration of the epidermis, T-cell
infiltration of the dermis and dermal vessel dilatation; Schon
and Boehncke, 2005).
The etiology of psoriasis is incompletely understood
(Barker, 1998), with its manifestations resulting from the
complex interplay of the immune system, the epidermal
barrier, and environmental factors. Although streptococcal
infection, medications, and trauma are involved in triggering
psoriasis (Krueger and Duvic, 1994; Fry and Baker, 2007),
greater attention has recently been focused on elucidating
genetic factors that influence susceptibility to psoriasis
(Bowcock and Cookson, 2004; Bowcock, 2005). The
epidemiology of psoriasis is consistent with it being a
polygenic disease where multiple genes with small effects
interact with one another and with the environment to
determine an individual’s propensity to develop psoriasis
(Bhalerao and Bowcock, 1998).
Independent studies of the major histocompatibility
complex in different ethnic groups consistently show an
association between psoriasis and the HLA-Cw6 allele
(Tiilikainen et al., 1980; Nair et al., 1997; Trembath et al.,
1997; Enlund et al., 1999a; Zhang et al., 2002; Sagoo et al.,
2004; Lesueur et al., 2007a). This locus at chromosome 6p21
has been dubbed psoriasis susceptibility locus 1 (PSORS1;
Elder et al., 1994a, b; Trembath et al., 1997). Although
PSORS1 is a predominant locus, it seems to be involved in
only 30–50% of psoriasis cases (Asumalahti et al., 2003).
Linkage studies on small groups of individuals have identified
other PSORS loci, including PSORS2 at 17q25 (Tomfohrde
et al., 1994), PSORS3 at 4qter (Matthews et al., 1996),
PSORS4 at 1q21 (Capon et al., 1999), PSORS5 at 3q21
(Enlund et al., 1999b), PSORS6 at 19p13 (Lee et al., 2000),
PSORS7 at 1p (Veal et al., 2001), PSORS8 at 16q (Nair et al.,
1997), and PSORS9 at 4q31-34. Additional susceptibility loci
and genes have also been postulated (International Psoriasis
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Genetics Consortium, 2003; Capon et al., 2004, 2008;
Lesueur et al., 2007b; Liu et al., 2008). The results of these
studies have proved difficult to replicate, because geographic
variations in psoriasis prevalence are compatible with both
genetic explanations that emphasize interethnic differences
and environmental variations. For example, only the
PSORS1, PSORS9 (Zhang et al., 2002; Fan et al., 2008),
9q33-34 (Sun et al., 2007), and 2p22.3-11.2 (Sun et al., 2008)
regions have been reported as susceptibility loci in the Han
Chinese. Moreover, the existence of more than one major
susceptibility gene is likely to decrease the ability to detect
linkage (Capon et al., 2000).
PSORS4, localized within chromosome 1q21, first
emerged as a potential PSORS from American and Italian
family studies (Bhalerao and Bowcock, 1998; Capon et al.,
1999). Fine mapping with densely spaced markers in 22
families of Italian descent further narrowed the region to a
350 kb interval in the distal portion of the epidermal
differentiation complex (EDC) (Capon et al., 2001). Recently,
a genome-wide association study of psoriasis and psoriatic
arthritis patients in the United States and United Kingdom
reported association of the disorder with a single-nucleotide
polymorphism (SNP) in the late cornified envelope 1C
(LCE1C) protein within the EDC (Liu et al., 2008). The EDC
spans 2mb in 1q21 and contains at least 45 genes involved in
skin cornification (Mischke et al., 1996; Hoffjan and
Stemmler, 2007), a differentiation process that leads to
formation of a functional epidermal barrier. The product of
these genes can be grouped into three families: the cornified
envelope precursor proteins, the keratin filament-associated
proteins and the S100 calcium-binding proteins. The first
family includes loricrin (LOR), involucrin (IVL), small proline-
rich proteins (SPRRs), and the family of late cornified
envelope (LCE) proteins. During cornification, these proteins
are cross-linked by transglutaminases to form a strong,
insoluble cornified envelope. The second family consists of
filaggrin (FLG), trichohyalin (TCHH), filaggrin2 (FLG2),
repetin (RPTN; Krieg et al., 1997), hornerin (HRNR; Makino
et al., 2001), and cornulin (CRNN; Contzler et al., 2005).
These proteins are important in bundling keratins to attain
flattened squames during cornification. In addition to their
structural role, it has been postulated that many of these
genes also participate in calcium-dependent processes
because they possess two EF-hand type calcium-binding
domains (Huber et al., 2005). The last family of genes in the
EDC belong to the S100 family that include small, calcium-
binding proteins involved in signaling and cell cycle
progression (Kligman and Hilt, 1988; Eckert et al., 2004).
As psoriasis displays abnormal epidermal differentiation,
the genes in the EDC cluster are biologically plausible
candidates for psoriasis susceptibility. In psoriatic patients,
upregulation of S100A7, S100A8, and S100A9 have been
observed in the epidermis (Saintigny et al., 1992; Hoffmann
et al., 1994) and LOR is downregulated (Giardina et al.,
2004). HRNR was reported to be expressed only in psoriatic
and regenerating skin (Takaishi et al., 2005).
The aim of this study was to identify gene(s) within the
EDC that confer susceptibility to psoriasis in Singaporean
Chinese psoriatic patients by high-density SNP genotyping
within the 2mb EDC region. The results provide evidence for
an association of psoriasis within the vicinity of IVL,
especially in early-onset psoriasis.
RESULTS
Clinical features
The majority of the psoriatics in the study had common
plaque psoriasis (471); there were 7 with palmoplantar
psoriasis, 9 with pustular psoriasis, and 4 with erythrodermic
psoriasis. There were three individuals with overlapping
features (one instance each of plaque and palmoplantar,
plaque and pustular, plaque and erythrodermic). A total of
494 Singaporean Chinese psoriatic individuals were even-
tually studied; 360 had an age of onset p40 years whereas
129 were diagnosed after the age of 40 (there was no clinical
data available for 5 individuals). For clarity purposes, all
genotyping data presented is derived from patients diagnosed
with common plaque psoriasis (474).
SNP genotyping of EDC candidate genes on the Sequenom
platform
The EDC locus maps to a 2.0mb interval in chromosome
1q21 and contains at least 45 genes whose products are
involved in the process of skin cornification (Mischke et al.,
1996; Hoffjan and Stemmler, 2007) We selected 11
candidate genes (Figure 1) from this region which was
previously associated with psoriasis susceptibility (Capon
et al., 1999; Sun et al., 2006). After SNP selection and
screening, we had an initial set of 94 SNPs extending from
positions 150346613 to 151500919 on chromosome 1 (NCBI
36). Once the analysis of this set was completed, a second set
of 22 SNPs, clustered in a region that showed statistically
significant association with psoriasis, was chosen from the
Genome Institute of Singapore SNP database and genotyped
together with 9 SNPs from the first set. Ultimately, 116 SNPs
were genotyped (Table 1).
After discarding 22 SNPs whose genotype data did not
conform to the Hardy–Weinberg equilibrium, the remaining
94 SNPs (listed in Table S1) were analysed. Significant
association (Po0.05) was detected with 3 SNPs mapped in
regions flanking IVL (Figure 1b; Table 2). Further statistical
analysis on early-onset (p40 years old at diagnosis) plaque
psoriasis patients revealed significant association with 11
SNPs clustered within 139 kb of the IVL region (Figure 1c).
The lowest P-value (0.00143) was obtained with rs6661932
located 12.3 kb downstream of IVL (Table 2).
Expanded analysis of EDC genes with the Infinium platform
The survey was expanded to the entire EDC with additional
DNA samples; data from 267 SNPs distributed in a 2mb
interval from positions 150000000 to 152000000 of chromo-
some 1 (NCBI 36) were analyzed in 428 plaque psoriasis
patients versus 571 normal controls after filtering out ethnic
outliers and members of first degree relative pairs (Table S2).
Statistically significant association (Po0.05) was still ob-
tained with a SNP (rs2879485) mapped to the vicinity of the
IVL gene. The expanded approach yielded an additional
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cluster of SNPs with statistical evidence for association with
psoriasis (Table 3). These SNPs are further downstream of IVL
and positioned within a 120 kb segment of EDC, between the
SPRR2A and LOR genes, which were not previously selected
for analysis with the Sequenom platform (Table 1). One of
these SNPs was located in the intron of SPRR2C pseudogene,
the rest were found in the neighborhood of the SPRR2F,
SPRR2G, late cornified envelope-like proline-rich protein 1
(LELP1), and proline-rich protein 9 (PRR9) genes (Table 3).
Concurrence of association in the above region was observed
in the subanalysis of early-onset plaque psoriasis patients
(Figure 1d); all SNPs located in IVL also showed significant
association (Table S2).
The linkage disequilibrium plot for a subset of the EDC
SNPs that encompass all that are statistically associated with
psoriasis is displayed in Figure 2. rs2879485 forms a small
linkage disequilibrium block of 5 kb (block 25) with
rs1854779 (350 bp upstream of IVL). The remaining SNPs
associated with psoriasis separate into 3 well-defined linkage
disequilibrium blocks (blocks 32, 35, and 36 that span 34, 17,
and 11 kb, respectively).
DISCUSSION
Psoriasis has been perceived and studied primarily as a
chronic inflammatory disorder (Bowcock, 2005). Changes in
the amounts of inflammatory cells and cytokines in the
dermis are thought to lead to epidermal hyperkeratosis and
parakeratosis as a secondary phenomenon (Ghoreschi et al.,
2007; Nickoloff et al., 2007). Recent advances in our
understanding of atopic dermatitis (eczema) may necessitate
a revision of this model. Recently, FLG has been shown
to be the major gene responsible for ichthyosis vulgaris
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Figure 1. SNP-based association analysis of candidate genes within chromosome 1q21. (a) Schematic diagram of candidate genes chosen for Sequenom
genotyping. (b) P-value plot of 94 SNPs genotyped by Sequenom in all plaque psoriasis patients; distribution of all these SNPs conforms to the Hardy–Weinberg
equilibrium. The red dotted line indicates the threshold of statistical significance (Po0.05). (c) P-value plot of 94 SNPs genotyped by Sequenom in early-onset
(p40 years old at diagnosis) plaque psoriasis patients; distribution of all these SNPs conforms to the Hardy–Weinberg equilibrium. The red dotted line indicates
the threshold of statistical significance (Po0.05). (d) A high resolution map of the region flanked by late cornified envelope 1A gene and loricrin genes and the
corresponding P-value plot of SNPs genotyped in early-onset (p40 years old) plaque psoriasis patients with Infinium (blue) and Sequenom (black) platforms
showing the close proximity of possible PS susceptibility locus.
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(Smith et al., 2006) and also contributes significantly to the
onset of atopic dermatitis and asthma in atopic dermatitis
patients (Palmer et al., 2006). Loss-of-function FLG mutations
were observed in as many as 50% of moderate-severe atopic
dermatitis cases (Sandilands et al., 2007) and also confer
major susceptibility to early-onset atopic dermatitis
(Barker et al., 2007). It has been suggested that the abnormal
cornification resulting from the FLG mutations disrupts
the epidermal barrier, allowing percutaneous entry of
antigens that trigger the inflammation observed in atopic
dermatitis. A similar pathogenetic mechanism in which
inflammation occurs secondarily to epidermal disarray
(Albanesi et al., 2007) may explain the association of
psoriasis with skin trauma. The search for psoriasis suscept-
ibility genes should therefore be widened to include genomic
regions that are important in skin cornification (Tschachler,
2007).
The proteins expressed by the genes encoded by the EDC,
of which filaggrin is one, are crucial in cornification. The
EDC itself maps to chromosome 1q21, the same locus as
PSORS4, which has previously been reported as a PSORS in
Europeans (Capon et al., 1999) and Americans (Bhalerao
Table 1. List of candidate genes in the epidermal differentiation complex chosen for SNP genotyping
Candidate genes/ genomic regions Chromosomal start Chromosomal end
Length
(kb)
No. of SNPs
genotyped
TCHH 150345417 150353180 7.76 5
RPTN 150392695 150398328 5.63 3
Region between RPTN and HRNR 150398329 150451175 52.8 35
HRNR 150451176 150463296 12.1 10
FLG 150541275 150564303 27.9 16
FLG2 150587837 150599106 11.3 8
CRNN 150648343 150653363 5.02 3
Region between CRNN and IVL 150653364 151147644 494 17
IVL 151147663 151150985 3.32 4
Region between IVL and SPRR1A 151150986 151223180 72.2 8
SPRR1A 151223181 151224913 1.73 2
SPRR3 151240849 151242956 2.11 2
SPRR2A 151295220 151296612 1.39 2
LOR 151498803 151501224 2.42 1
Total 116
SNP, single-nucleotide polymorphism.
Table 2. SNPs showing significant P-values in Sequenom genotyping
SNP
Chromosomal
location
Gene
annotation Remarks
Major/minor
allele
P-value (all
cases versus controls)
P-value (early-onset
cases versus controls)
rs4845325 151065184 LCE1A intron NA G/A 0.0686 0.0135
rs2339396 151108924 — NA G/A 0.1737 0.0362
*rs11205128 151110766 — NA G/A 0.0091 0.0016
rs3737861 151117562 SMCP intron NA T/G 0.1414 0.0244
rs16834751 151147835 IVL intron NA A/C 0.2079 0.0160
rs11205132 151148759 IVL intron NA A/G 0.1628 0.0360
rs2229496 151149234 IVL exon 2 Nonsynonymous G/A 0.0558 0.0051
rs913996 151150735 IVL 3’ UTR NA C/T 0.1618 0.0129
*rs6661932 151163358 downstream of IVL 12.3 kb C/T 0.0106 0.0014
*rs4845497 151170786 downstream of IVL 19.8 kb C/T 0.0359 0.0037
rs4845501 151204025 — NA A/G 0.1312 0.0379
NA, not applicable; SNP, single-nucleotide polymorphism.
The chromosomal location is based on NCBI build 36 and dbSNP 126.
*SNPs with significant P-values (o0.05) in all psoriasis cases versus controls and early-onset (p40 years old at diagnosis) psoriasis cases versus controls.
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and Bowcock, 1998). However, this locus has not been
previously associated with psoriasis in any Asian population.
Involucrin, filaggrin, and loricrin are the major components
of the cornified envelope. Previous analyses of mutations and
SNPs in the FLG and LOR genes indicate that both of them
are unlikely to be the gene(s) that confer susceptibility to
Table 3. Human HapMap 550v3 SNPs along the EDC within chromosome 1q21 showing significant P-values in
Infinium genotyping
SNP
Chromosomal
location Gene annotation Remarks
Major/minor
allele
P-value (all cases
versus controls
rs1011297 150864572 Upstream of LCE3A 2639 bp T/C 0.0378
rs7543194 150940844 Downstream of LCE2A 2303 bp T/C 0.0477
rs2879485 151152537 Downstream of IVL 1551 bp G/A 0.0294
rs1500941 151354285 Downstream of SPRR2F 1672 bp A/G 0.0212
rs428913 151368112 Upstream of SPRR2G 11479 bp C/T 0.0319
rs509194 151388795 SPRR2C1 intron NA A/G 0.0134
rs10494291 151448915 Downstream of LELP1 4695 bp G/T 0.0375
rs10494292 151450469 Downstream of LELP1/
upstream of PRR9
6249 bp/6215 bp T/G 0.0012
rs10788861 151452018 Upstream of PRR9 4666 bp C/A 0.0023
rs1410859 151456561 Upstream of PRR92 123 bp G/A 0.0121
rs1410860 151456602 Upstream of PRR92 82 bp A/G 0.0033
rs12127862 151464064 Downstream of PRR9 5647 bp G/A 0.0031
rs10888541 151476212 Downstream of PRR9 17795 bp A/G 0.0345
rs4845342 151477432 Downstream of PRR9 19015 bp C/A 0.0353
EDC, epidermal differentiation complex; NA, not applicable; SNP, single-nucleotide polymorphism.
1Unprocessed pseudogene.
2Possible promoter region of PRR9.
Figure 2. Linkage disequilibrium (LD) plot of 62 contiguous SNPs from the Human HapMap 550v3 panel, including all that are significantly associated with
psoriasis. This subset of EDC SNPs extends from positions 151136387 to 151479292 (dbSNP 126) and includes all that are significantly associated with
psoriasis. They group into 12 haplotype blocks (blocks 25–36). SNPs that are excluded from the blocks were filtered using criteria specified in the text.
610 Journal of Investigative Dermatology (2009), Volume 129
H Chen et al.
Association of PSORS4 with Singaporean Psoriasis
psoriasis in PSORS4 (Giardina et al., 2004; Zhao et al., 2007).
However, SNPs from the LCE family cluster and peptidogly-
can recognition protein coding region, that lie between FLG and
S100A9 genes, have shown association with psoriasis in a
genome-wide association study and family-based Caucasian
patient cohort respectively (Sun et al., 2006; Liu et al., 2008).
Our preliminary association study of 11 selected genes
within the EDC revealed 3 SNPs in the vicinity of IVL with
significant P-values (0.0090 oPo0.040; Table 2); subana-
lysis of early-onset patients revealed significant association of
11 SNPs (0.0016oPo0.040) clustered within 139 kb of IVL,
highlighting the presence of a strong genetic component in
early-onset plaque psoriasis (Henseler and Christophers,
1985). Involucrin was the first structural protein to be
identified as a cornified envelope component and has been
reported to be show abnormal expression in psoriatic skin
(Ishida-Yamamoto and Iizuka, 1995; Pena-Penabad et al.,
1999). Involucrin is an early component in the process of skin
cornification—it becomes cross-linked to many structural
proteins in the epidermal layer, serving as a scaffold to aid the
subsequent maturation of the stratum corneum. Regulation of
involucrin expression is complex and involves spatially
distinct regulatory elements (Crish et al., 2002). The proximal
regulatory region containing AP1-1 and C/EBP transcription
factor binding sites lies directly upstream of exon 1 whereas
the distal regulatory region between 2473/1953 include
ISE, AP1-5, and Sp1 binding sites (Crish et al., 2006). Of the
11 SNPs, 4 that scored as significant in early-onset psoriasis
are within the IVL gene, 4 others are in close proximity to the
distal regulatory region, and two others are 12.3 and 19.8 kb
downstream of IVL, respectively (Table 2). This region may
also harbor transcription factor binding sites that participate
in the complex regulation of the involucrin gene previously
alluded to.
Our subsequent expanded analysis of the EDC revealed
further interesting insights. Borderline evidence (0.030
oPo0.050) was detected with 2 SNPs in the LCE family
and a SNP in the flanking region of IVL; another distinct
cluster of 11 SNPs significantly associated with psoriasis
(0.0014oPo0.049) was identified within a 120 kb region of
EDC 200 kb distal from IVL (Table 3; Figure 1c). This region
includes SPRR2F SPRR2G, SPRR2C, PRR9, and LELP1 genes.
A literature search revealed that these genes have been less
intensively studied than other EDC components. SPRRs, also
known as cornifins, are precursors of the cornified envelope
and are more conspicuously expressed in psoriatic skin
(Iizuka et al., 2004). LELP1 has not previously been
associated with psoriasis, although SNPs in its proximity are
associated with elevated immunoglobulin E levels, a feature
of atopic dermatitis (Sharma et al., 2007). The majority of the
SNPs are positioned in the surrounding region of PRR9, of
which rs14100859 and rs1410860 are polymorphisms that
could potentially affect promoter activity (Table 3). Interest-
ingly, subanalysis of early-onset plaque psoriasis patients
revealed significant association (Po0.05) for all IVL SNPs,
supporting our Sequenom genotyping data and reaffirming
the possible involvement of this region in psoriasis suscept-
ibility (Table S2).
Our data confirming PSORS4 as a susceptibility locus in
Singaporean Chinese are consistent with previous findings in
Caucasians that polymorphisms in precursor proteins of
cornified envelope genes are associated with susceptibility
to psoriasis (Capon et al., 2001; Sun et al., 2006; Liu et al.,
2008). The observation of enhanced association of PSORS4
in early-onset psoriasis patients supports the hypothesis that
an altered skin barrier from birth can expose an individual to
more environmental irritants, leading to an early-onset of
inflammatory skin disorders like psoriasis and atopic derma-
titis (Barker et al., 2007). Despite the recent discovery of FLG
as an important gene in the maintenance of an efficient
epidermal barrier (Irvine and McLean, 2006), our data
confirms, in line with Zhao et al. (2007), that FLG is probably
not important in psoriasis (Figure 1b).
In conclusion, we have identified two clusters of SNPs
lying among genes responsible for skin barrier formation in
the PSORS4 locus that show significant association with
psoriasis in Singaporean Chinese. These clusters are enriched
in the early-onset patients. It will be interesting to see if our
findings are replicated in other populations, especially in
neighboring Asian regions.
MATERIALS AND METHODS
Clinical samples
Singaporean Chinese patients with psoriasis were clinically ascer-
tained and recruited through the Psoriasis Clinic of the National Skin
Centre, Singapore, and unaffected Singaporean Chinese with a
similar age and gender distribution to the patients were selected as
controls from stored samples in the Singapore Tissue Network.
Informed consent was obtained under protocols approved by the
Institutional Review Boards of the participating institutions, which
are in accordance with the Declaration of Helsinki Principles.
DNA extraction was performed within the Singapore Tissue
Network facilities using the Gentra PureGene Cell Kit (Qiagen,
Hilden, Germany; www.qiagen.com).
The first analysis was performed with DNA extracted from 405
patients and 431 controls, whereas the second experiment was
carried out with the same set of samples and additional DNA,
collected from a total of 494 patients and 588 controls.
Candidate gene and SNP selection
For Sequenom analysis, 11 candidate genes were chosen by virtue of
their function in skin differentiation and localization to the distal
350 kb of the EDC (Table 1). All SNPs within these candidates and in
100 kb regions upstream and downstream of them were identified
through the Genome Institute of Singapore SNP collective database.
A subset of biallelic SNPs spaced at approximately 1.5 kb intervals in
the region of these candidate genes was selected, with priority given
to those which had previously been validated and shown to be
present in the Han Chinese with minor allele frequency X10%
wherever possible. These were then screened with the RealSNP tool
(Sequenom, San Diego, CA; www.realsnp.com) to remove SNPs
with ambiguous or highly repetitive flanking sequences.
In order to further analyze the initial findings, we decided to
examine the entire EDC with 267 SNPs from the Human HapMap
550v3 panel (Illumina, San Diego, CA) that were located in
an interval spanning positions 150000000 to 152000000 in
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chromosome 1 based on NCBI build 36 and dbSNP build 126 data
(Table S2).
Genotyping
Two sets of assay were performed using different genotyping
technologies. SNPs selected from the Genome Institute of Singapore
SNP database were genotyped on 405 patients and 431 controls
using Sequenom MassARRAY technology (Sequenom; www.
sequenom.com). The iPLEX assay was performed according to the
manufacturer’s instructions (www.sequenom.com). Briefly, PCR and
extension reactions were designed by the MassARRAY design
software, and were carried out using 5 ng of template DNA. The
unincorporated nucleotides in the PCR product were deactivated
with shrimp alkaline phosphatase. SNP sites were amplified using
MassExtend primers in a termination master mix with differentially
labeled ddNTPs. The primer extension products were desalted with
the Clean Resin, spotted onto a SpectroCHIP bioarray, and MALDI-
TOF MS analysis was performed with MassARRAY Workstation
version 3.3 software. Resulting spectra were analyzed and genotypes
were determined using the Sequenom TYPER software.
The Human HapMap SNPs were genotyped with the Infinium
assay protocol (Illumina; www.illumina.com) on 750ng of genomic
DNA each from 494 patients and 588 controls (including
all individuals from the first set) using the standard reagent kit
provided. Genotypes were assigned with BeadStudio 3.0 software
(Illumina).
Statistical analysis
Genotype data derived from the Sequenom platform was analyzed
with HelixTree 2.0 software (Golden Helix, Bozeman, MT;
www.goldenhelix.com). Allele-based association studies were per-
formed with missing alleles excluded from analysis. Analysis for
conformation with the Hardy–Weinberg equilibrium was performed
with a w2-test to identify potential errors in genotype calls, and SNPs
that yielded P-values o0.05 were discarded.
The genotype data from the Infinium platform was initially
subjected to a quality check with BeadStudio 3.0 and SNPs with call
frequencies o88% and samples with call rates o96% were
discarded. Data from the remaining 469 patients and 585 controls
was analyzed with PLINK, a toolset for whole genome association
analysis (http://pngu.mgh.harvard.edu/~purcell/plink). Three filters
were applied to the data:
(i) a gender concordance check;
(ii) detection of ethnic outliers using principal components
analysis as implemented in the program EIGENSTRAT (Price
et al., 2006);
(iii) detection of first-degree relatives (one of each pair was
dropped from subsequent analysis for association).
The Cochran–Armitage TREND test was then used for association
analysis on the filtered data whereas conformation with the
Hardy–Weinberg equilibrium was checked using the exact test
(Wigginton et al., 2005). Age-stratified analysis of the filtered data
was performed with 313 early-onset (p40 years old at diagnosis)
and 111 late-onset (440 years old at diagnosis) plaque psoriasis
patients after discarding data with no information on the age of
onset.
The Infinium genotype data from the controls was analyzed for
linkage disequilibrium using Haploview 4.0 (http://www.broad.
mit.edu/mpg/haploview). Standard filtering procedures were imple-
mented (Hardy–Weinberg, P-value o0.001, percentage of non-
missing genotypes o75%, number of Mendelian errors 40, minor
allele frequency o0.001).
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